IP Verse

Use Of A Combination Comprising A Btk Inhibitor For Treating Cancers

Patent No. EP3500299 (titled "Use Of A Combination Comprising A Btk Inhibitor For Treating Cancers") was filed by Beigene on Aug 18, 2017. The application was issued on Dec 13, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KERNEBECK PATENTANWALTSSep 13, 2024KERNEBECK
TEVA PHARMACEUTICALSSep 12, 2024D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3500299

BEIGENE
Application Number
EP17841107A
Filing Date
Aug 18, 2017
Status
Granted And Under Opposition
Nov 10, 2023
Publication Date
Dec 13, 2023
External Links
Slate, Register , Google Patents